Table 2

Univariate analysis of associations of patient, tumor, treatment, and pathologic characteristics with survival

VariableTime to failure survivalOverall survival
95% CIP value95% CIP value
TNM stage4.906–18.4270.2167.128–41.2060.007*
IORT dose ≤ 15 (vs. > 15)2.382–12.8180.5300.001–56.1590.984
D-dimer < 500 (vs. ≥ 500)4.906–18.4270.005*10.267–38.0670.016*
CEA < 5 (vs. ≥ 5)4.906–18.4270.036*7.790–20.6100.002*
CA19-9 < 37 (vs. ≥ 37)0.715–16.2190.11210.520–18.9460.001*
  • *P < 0.05 was considered statistically significant. CI, confidence interval.